8% dávky se vylučuje ledvinami a celková plasmatická clearance přípravku se u osob s poškozením ledvin snižuje.
Eight percent of one dose of repaglinide is excreted through the kidneys and total plasma clearance of the product is decreased in patients with renal impairment.